#mapguide search results

New on the MAPGuide 📖 Protalix BioTherapeutics & Fiocruz (Brazil) sign a technology transfer and supply agreement for enzyme replacement therapy for Gaucher Disease. 🔗 ghiaa.org/mapguide-home/… #MAPGuide #GlobalHealth #TechnologyTransfer

GHIAAteam's tweet image. New on the MAPGuide 📖
Protalix BioTherapeutics & Fiocruz (Brazil) sign a technology transfer and supply agreement for enzyme replacement therapy for Gaucher Disease.

🔗 ghiaa.org/mapguide-home/…
#MAPGuide #GlobalHealth #TechnologyTransfer

New on the MAPGuide 📖 @MedinCell & MPP sign a license for mdc-STM, a 3-month injectable ivermectin using BEPO® tech. The deal includes affordable pricing, timely supply, and access commitments for LMICs. 🔗Read more - ghiaa.org/mapguide-home/…+ #MAPGuide #GlobalHealth #Malaria

GHIAAteam's tweet image. New on the MAPGuide 📖

@MedinCell & MPP sign a license for mdc-STM, a 3-month injectable ivermectin using BEPO® tech.
The deal includes affordable pricing, timely supply, and access commitments for LMICs.

🔗Read more - ghiaa.org/mapguide-home/…+
#MAPGuide #GlobalHealth #Malaria

Announcing a tool designed to make equitable access agreements just a little bit clearer. Coming November 27, 2023. #GlobalHealth #EquitableAccess #MAPGuide


Reflections, interview, conferences, and an addition to the #MAPGuide - check out our March newsletter now! linkedin.com/pulse/policies…

GHIAAteam's tweet image. Reflections, interview, conferences, and an addition to the #MAPGuide - check out our March newsletter now! linkedin.com/pulse/policies…

New on the #MAPGuide: Indian Department of Biotechnology (DBT) MOU Read the full agreement here: ghiaa.org/mapguide-home/… Explore more on the MAPGuide here: ghiaa.org/mapguide-home/

GHIAAteam's tweet image. New on the #MAPGuide: Indian Department of Biotechnology (DBT) MOU

Read the full agreement here: ghiaa.org/mapguide-home/…

Explore more on the MAPGuide here: ghiaa.org/mapguide-home/

New on the #MAPGuide: @WellcomeTrust Standard Grant Terms & Conditions. Read full T&Cs here: ow.ly/V7kN50SjCcA

GHIAAteam's tweet image. New on the #MAPGuide: @WellcomeTrust  Standard Grant Terms & Conditions. 

Read full T&Cs here: ow.ly/V7kN50SjCcA

New on the #MAPGuide: This agreement includes a Most Favored Customer provision under which Inovio agrees that it will not sell the production model of the Prototype to any entity at a lower price than that offered to the DoD. Read the agreement here: ow.ly/LeMn50Q6yBb

GHIAAteam's tweet image. New on the #MAPGuide:  This agreement includes a Most Favored Customer provision under which Inovio agrees that it will not sell the production model of the Prototype to any entity at a lower price than that offered to the DoD. 

Read the agreement here: ow.ly/LeMn50Q6yBb

New on the #MAPGuide: This agreement contains requirements including provision of a report on the potential Public Sector requirements for a Licensed Product to meet needs in #LMIC and a plan for fulfilling those requirements. Read the full agreement: ow.ly/ROgL50Q4na5

GHIAAteam's tweet image. New on the #MAPGuide: This agreement contains requirements including provision of a report on the potential Public Sector requirements for a Licensed Product to meet needs in #LMIC and a plan for fulfilling those requirements.

Read the full agreement: ow.ly/ROgL50Q4na5

New on the #MAPGuide: Licensee obligations include ensuring that products sold in the U.S. are substantially manufactured in the U.S. & making the product available to patient assistance programs. Read the full agreement: ow.ly/ctTx50Q4nbI

GHIAAteam's tweet image. New on the #MAPGuide: Licensee obligations include ensuring that products sold in the U.S. are substantially manufactured in the U.S. & making the product available to patient assistance programs.

Read the full agreement: ow.ly/ctTx50Q4nbI

New on the #MAPGuide®: The agreement contains specific “Developing World Access” requirements, including a report on the potential Public Sector needs for a Licensed Product and preferential pricing for the Public Sector. Read more: ow.ly/K3Ru50Q4mY4

GHIAAteam's tweet image. New on the #MAPGuide®: The agreement contains specific “Developing World Access” requirements, including a report on the potential Public Sector needs for a Licensed Product and preferential pricing for the Public Sector.

Read more: ow.ly/K3Ru50Q4mY4

Crack the code of @bloodstrike_EN with our ultimate map guide! 🗺️ Learn the ins and outs of each location to outplay your opponents and secure victory! 💪 🔗Check out the complete list 👉 bit.ly/BloodStrike_Ma… #BloodStrike #MapGuide #GamingTips

bluestacksinc's tweet image. Crack the code of @bloodstrike_EN with our ultimate map guide! 🗺️ 

Learn the ins and outs of each location to outplay your opponents and secure victory! 💪 

🔗Check out the complete list 👉 bit.ly/BloodStrike_Ma…

#BloodStrike #MapGuide #GamingTips

New on the #MAPGuide: This Agreement is between Medigen, a private corporation located in Taipei, and @MedsPatentPool and is effective as of July 2023. Read the agreement here: ghiaa.org/mapguide-home/… Explore the MAPGuide® here: ghiaa.org/mapguide-home/

GHIAAteam's tweet image. New on the #MAPGuide: This Agreement is between Medigen, a private corporation located in Taipei, and @MedsPatentPool and is effective as of July 2023.

Read the agreement here: ghiaa.org/mapguide-home/…

Explore the MAPGuide® here: ghiaa.org/mapguide-home/

New on the #MAPGuide:!@udechile@MedsPatentPool (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement: The Agreement provides a worldwide, non-exclusive license with the goal of making them accessible worldwide. Read the agreement here: ow.ly/rrrE50Q6yFW+

GHIAAteam's tweet image. New on the #MAPGuide:!@udechile– @MedsPatentPool (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement: The Agreement provides a worldwide, non-exclusive license with the goal of making them accessible worldwide.

Read the agreement here: ow.ly/rrrE50Q6yFW+

New on the #MAPGuide: @Pop_Council - @TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement. The Agreement includes public announcement of a reduced price program for underrepresented communities as part of an Outreach Plan. ghiaa.org/mapguide-home/…

GHIAAteam's tweet image. New on the #MAPGuide: @Pop_Council - @TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement. The Agreement includes public announcement of a reduced price program for underrepresented communities as part of an Outreach Plan. 
ghiaa.org/mapguide-home/…

New on the #MAPGuide: Under this agreement, @uniQure and @NIH agreed to a reduction in the payments required for sublicensing in order to expedite the development of therapeutics for rare diseases. Read the agreement here: ow.ly/zt6a50Q6yNV

GHIAAteam's tweet image. New on the #MAPGuide: Under this agreement, @uniQure and @NIH agreed to a reduction in the payments required for sublicensing in order to expedite the development of therapeutics for rare diseases.

Read the agreement here: ow.ly/zt6a50Q6yNV

New on the #MAPGuide®: PHS (@NIH /@CDCgov /@US_FDA ) Obligations include ensuring that products sold in the U.S. are substantially manufactured in the U.S. & making efforts to ensure that the product is reasonably accessible to the U.S. public. ow.ly/cbgA50Q6yrH

GHIAAteam's tweet image. New on the #MAPGuide®: PHS (@NIH /@CDCgov /@US_FDA ) Obligations include ensuring that products sold in the U.S. are substantially manufactured in the U.S. & making efforts to ensure that the product is reasonably accessible to the U.S. public. 

ow.ly/cbgA50Q6yrH

How to Set Amap (Gaode Map) to English: First-Time Setup and Language Change 🗺️🌏 Navigate China like a pro with this simple language guide for China's top map app! 👇 gotochinanow.com/article/how-to… #ChinaApps #MapGuide #TravelTech #NavigationTips #ChineseApps


Why did the dad carry a map to the amusement park? To show his kids the route to all the "dad jokes"! 🗺️🎢 #DadJoke #AmusementParkFun #MapGuide #FamilyTrip 😂👨‍👧‍👦


New on the MAPGuide 📖 Protalix BioTherapeutics & Fiocruz (Brazil) sign a technology transfer and supply agreement for enzyme replacement therapy for Gaucher Disease. 🔗 ghiaa.org/mapguide-home/… #MAPGuide #GlobalHealth #TechnologyTransfer

GHIAAteam's tweet image. New on the MAPGuide 📖
Protalix BioTherapeutics & Fiocruz (Brazil) sign a technology transfer and supply agreement for enzyme replacement therapy for Gaucher Disease.

🔗 ghiaa.org/mapguide-home/…
#MAPGuide #GlobalHealth #TechnologyTransfer

New on the MAPGuide 📖 @MedinCell & MPP sign a license for mdc-STM, a 3-month injectable ivermectin using BEPO® tech. The deal includes affordable pricing, timely supply, and access commitments for LMICs. 🔗Read more - ghiaa.org/mapguide-home/…+ #MAPGuide #GlobalHealth #Malaria

GHIAAteam's tweet image. New on the MAPGuide 📖

@MedinCell & MPP sign a license for mdc-STM, a 3-month injectable ivermectin using BEPO® tech.
The deal includes affordable pricing, timely supply, and access commitments for LMICs.

🔗Read more - ghiaa.org/mapguide-home/…+
#MAPGuide #GlobalHealth #Malaria

New on the #MAPGuide: Indian Department of Biotechnology (DBT) MOU Read the full agreement here: ghiaa.org/mapguide-home/… Explore more on the MAPGuide here: ghiaa.org/mapguide-home/

GHIAAteam's tweet image. New on the #MAPGuide: Indian Department of Biotechnology (DBT) MOU

Read the full agreement here: ghiaa.org/mapguide-home/…

Explore more on the MAPGuide here: ghiaa.org/mapguide-home/

New on the #MAPGuide: @Pop_Council - @TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement. The Agreement includes public announcement of a reduced price program for underrepresented communities as part of an Outreach Plan. ghiaa.org/mapguide-home/…

GHIAAteam's tweet image. New on the #MAPGuide: @Pop_Council - @TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement. The Agreement includes public announcement of a reduced price program for underrepresented communities as part of an Outreach Plan. 
ghiaa.org/mapguide-home/…

New on the #MAPGuide: @WellcomeTrust Standard Grant Terms & Conditions. Read full T&Cs here: ow.ly/V7kN50SjCcA

GHIAAteam's tweet image. New on the #MAPGuide: @WellcomeTrust  Standard Grant Terms & Conditions. 

Read full T&Cs here: ow.ly/V7kN50SjCcA

Why did the dad carry a map to the amusement park? To show his kids the route to all the "dad jokes"! 🗺️🎢 #DadJoke #AmusementParkFun #MapGuide #FamilyTrip 😂👨‍👧‍👦


Parachute like a pro and loot like a legend! 🪂 Our ultimate PUBG map guide reveals the best landing spots and hidden loot caches on every map. 👉 gato.gg/pubg-map-guide/ ---- #PUBG #BattleRoyale #MapGuide #GamingTips


Reflections, interview, conferences, and an addition to the #MAPGuide - check out our March newsletter now! linkedin.com/pulse/policies…

GHIAAteam's tweet image. Reflections, interview, conferences, and an addition to the #MAPGuide - check out our March newsletter now! linkedin.com/pulse/policies…

New on the MAPGuide 📖 @MedinCell & MPP sign a license for mdc-STM, a 3-month injectable ivermectin using BEPO® tech. The deal includes affordable pricing, timely supply, and access commitments for LMICs. 🔗Read more - ghiaa.org/mapguide-home/…+ #MAPGuide #GlobalHealth #Malaria

GHIAAteam's tweet image. New on the MAPGuide 📖

@MedinCell & MPP sign a license for mdc-STM, a 3-month injectable ivermectin using BEPO® tech.
The deal includes affordable pricing, timely supply, and access commitments for LMICs.

🔗Read more - ghiaa.org/mapguide-home/…+
#MAPGuide #GlobalHealth #Malaria

New on the MAPGuide 📖 Protalix BioTherapeutics & Fiocruz (Brazil) sign a technology transfer and supply agreement for enzyme replacement therapy for Gaucher Disease. 🔗 ghiaa.org/mapguide-home/… #MAPGuide #GlobalHealth #TechnologyTransfer

GHIAAteam's tweet image. New on the MAPGuide 📖
Protalix BioTherapeutics & Fiocruz (Brazil) sign a technology transfer and supply agreement for enzyme replacement therapy for Gaucher Disease.

🔗 ghiaa.org/mapguide-home/…
#MAPGuide #GlobalHealth #TechnologyTransfer

Reflections, interview, conferences, and an addition to the #MAPGuide - check out our March newsletter now! linkedin.com/pulse/policies…

GHIAAteam's tweet image. Reflections, interview, conferences, and an addition to the #MAPGuide - check out our March newsletter now! linkedin.com/pulse/policies…

New on the #MAPGuide: @WellcomeTrust Standard Grant Terms & Conditions. Read full T&Cs here: ow.ly/V7kN50SjCcA

GHIAAteam's tweet image. New on the #MAPGuide: @WellcomeTrust  Standard Grant Terms & Conditions. 

Read full T&Cs here: ow.ly/V7kN50SjCcA

New on the #MAPGuide: Indian Department of Biotechnology (DBT) MOU Read the full agreement here: ghiaa.org/mapguide-home/… Explore more on the MAPGuide here: ghiaa.org/mapguide-home/

GHIAAteam's tweet image. New on the #MAPGuide: Indian Department of Biotechnology (DBT) MOU

Read the full agreement here: ghiaa.org/mapguide-home/…

Explore more on the MAPGuide here: ghiaa.org/mapguide-home/

New on the #MAPGuide: This agreement contains requirements including provision of a report on the potential Public Sector requirements for a Licensed Product to meet needs in #LMIC and a plan for fulfilling those requirements. Read the full agreement: ow.ly/ROgL50Q4na5

GHIAAteam's tweet image. New on the #MAPGuide: This agreement contains requirements including provision of a report on the potential Public Sector requirements for a Licensed Product to meet needs in #LMIC and a plan for fulfilling those requirements.

Read the full agreement: ow.ly/ROgL50Q4na5

October's newsletter is out now and includes #MAPGuide updates and our comments on the #NegotiatingText for the @WHO convention, agreement or other international instrument on pandemic prevention, preparedness, and response. ow.ly/ipRv50Q1LIw

GHIAAteam's tweet image. October's newsletter is out now and includes #MAPGuide updates and our comments on the #NegotiatingText for the @WHO convention, agreement or other international instrument on pandemic prevention, preparedness, and response.

ow.ly/ipRv50Q1LIw

New on the #MAPGuide: This agreement includes a Most Favored Customer provision under which Inovio agrees that it will not sell the production model of the Prototype to any entity at a lower price than that offered to the DoD. Read the agreement here: ow.ly/LeMn50Q6yBb

GHIAAteam's tweet image. New on the #MAPGuide:  This agreement includes a Most Favored Customer provision under which Inovio agrees that it will not sell the production model of the Prototype to any entity at a lower price than that offered to the DoD. 

Read the agreement here: ow.ly/LeMn50Q6yBb

It's the best time of the month - newsletter time! We've got a snazzy new How-To video for the #MAPGuide, some exciting events lined up, and some good summer reads (and watches!) in our July newsletter. linkedin.com/pulse/policies…

GHIAAteam's tweet image. It's the best time of the month - newsletter time! We've got a snazzy new How-To video for the #MAPGuide, some exciting events lined up, and some good summer reads (and watches!) in our July newsletter. linkedin.com/pulse/policies…

New on the #MAPGuide: Licensee obligations include ensuring that products sold in the U.S. are substantially manufactured in the U.S. & making the product available to patient assistance programs. Read the full agreement: ow.ly/ctTx50Q4nbI

GHIAAteam's tweet image. New on the #MAPGuide: Licensee obligations include ensuring that products sold in the U.S. are substantially manufactured in the U.S. & making the product available to patient assistance programs.

Read the full agreement: ow.ly/ctTx50Q4nbI

New on the #MAPGuide®: The agreement contains specific “Developing World Access” requirements, including a report on the potential Public Sector needs for a Licensed Product and preferential pricing for the Public Sector. Read more: ow.ly/K3Ru50Q4mY4

GHIAAteam's tweet image. New on the #MAPGuide®: The agreement contains specific “Developing World Access” requirements, including a report on the potential Public Sector needs for a Licensed Product and preferential pricing for the Public Sector.

Read more: ow.ly/K3Ru50Q4mY4

New on the #MAPGuide: @DNDi Template Development Collaboration and License Agreement (“DCLA”). The DCLA includes additional access-related provisions such as a requirement to draw-up a high level Access and Implementation Plan Read it here: ow.ly/73nf50P4lOm

GHIAAteam's tweet image. New on the #MAPGuide: @DNDi Template Development Collaboration and License Agreement (“DCLA”). The DCLA includes additional access-related provisions such as a requirement to draw-up a high level Access and Implementation Plan

Read it here: ow.ly/73nf50P4lOm

New on the #MAPGuide: @DNDi Template Research Collaboration & License Agreement. The RCLA sets the expectation that any Development Program will prioritize affordable distribution of the product in all countries in which the disease is endemic. Read it: ow.ly/M1HP50P4lcJ

GHIAAteam's tweet image. New on the #MAPGuide: @DNDi Template Research Collaboration & License Agreement. The RCLA sets the expectation that any Development Program will prioritize affordable distribution of the product in all countries in which the disease is endemic.
Read it: ow.ly/M1HP50P4lcJ

Crack the code of @bloodstrike_EN with our ultimate map guide! 🗺️ Learn the ins and outs of each location to outplay your opponents and secure victory! 💪 🔗Check out the complete list 👉 bit.ly/BloodStrike_Ma… #BloodStrike #MapGuide #GamingTips

bluestacksinc's tweet image. Crack the code of @bloodstrike_EN with our ultimate map guide! 🗺️ 

Learn the ins and outs of each location to outplay your opponents and secure victory! 💪 

🔗Check out the complete list 👉 bit.ly/BloodStrike_Ma…

#BloodStrike #MapGuide #GamingTips

New on the #MAPGuide: This Agreement is between Medigen, a private corporation located in Taipei, and @MedsPatentPool and is effective as of July 2023. Read the agreement here: ghiaa.org/mapguide-home/… Explore the MAPGuide® here: ghiaa.org/mapguide-home/

GHIAAteam's tweet image. New on the #MAPGuide: This Agreement is between Medigen, a private corporation located in Taipei, and @MedsPatentPool and is effective as of July 2023.

Read the agreement here: ghiaa.org/mapguide-home/…

Explore the MAPGuide® here: ghiaa.org/mapguide-home/

New on the #MAPGuide:!@udechile@MedsPatentPool (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement: The Agreement provides a worldwide, non-exclusive license with the goal of making them accessible worldwide. Read the agreement here: ow.ly/rrrE50Q6yFW+

GHIAAteam's tweet image. New on the #MAPGuide:!@udechile– @MedsPatentPool (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement: The Agreement provides a worldwide, non-exclusive license with the goal of making them accessible worldwide.

Read the agreement here: ow.ly/rrrE50Q6yFW+

New on the #MAPGuide: @Pop_Council - @TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement. The Agreement includes public announcement of a reduced price program for underrepresented communities as part of an Outreach Plan. ghiaa.org/mapguide-home/…

GHIAAteam's tweet image. New on the #MAPGuide: @Pop_Council - @TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement. The Agreement includes public announcement of a reduced price program for underrepresented communities as part of an Outreach Plan. 
ghiaa.org/mapguide-home/…

New on the #MAPGuide: Under this agreement, @uniQure and @NIH agreed to a reduction in the payments required for sublicensing in order to expedite the development of therapeutics for rare diseases. Read the agreement here: ow.ly/zt6a50Q6yNV

GHIAAteam's tweet image. New on the #MAPGuide: Under this agreement, @uniQure and @NIH agreed to a reduction in the payments required for sublicensing in order to expedite the development of therapeutics for rare diseases.

Read the agreement here: ow.ly/zt6a50Q6yNV

On the #MAPGuide: @MedsPatentPool retains right to share data generated under the mRNA tech transfer project with @WHO which may then share the data with 3rd party funders to facilitate the dev & equitable access of technologies in LMIC. Read it here: ow.ly/yZhH50Ol1ge

GHIAAteam's tweet image. On the #MAPGuide: @MedsPatentPool retains  right to share data generated under the mRNA tech transfer project with @WHO which may then share the data with 3rd party funders to facilitate the dev &  equitable access of  technologies in LMIC.

Read it here: ow.ly/yZhH50Ol1ge

New on the #MAPGuide®: PHS (@NIH /@CDCgov /@US_FDA ) Obligations include ensuring that products sold in the U.S. are substantially manufactured in the U.S. & making efforts to ensure that the product is reasonably accessible to the U.S. public. ow.ly/cbgA50Q6yrH

GHIAAteam's tweet image. New on the #MAPGuide®: PHS (@NIH /@CDCgov /@US_FDA ) Obligations include ensuring that products sold in the U.S. are substantially manufactured in the U.S. & making efforts to ensure that the product is reasonably accessible to the U.S. public. 

ow.ly/cbgA50Q6yrH

Loading...

Something went wrong.


Something went wrong.


United States Trends